Informations générales (source: ClinicalTrials.gov)

NCT02666612 Statut inconnu
Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic Cancer
Interventional
  • Cellules tumorales circulantes
  • Métastase tumorale
  • Tumeurs
  • Seconde tumeur primitive
N/A
Gustave Roussy, Cancer Campus, Grand Paris (Voir sur ClinicalTrials)
août 2008
août 2023
11 septembre 2025
Monitoring of circulating endothelial cells (CEC and mature cells called progenitors called CEP) or circulating tumor cells (CTC) in adult patients with metastatic cancer, possibly treated with targeted therapy.
 Voir le détail

Etablissements

Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
CLCC INSTITUT GUSTAVE ROUSSY Jean Charles Soria, MD-PhD En recrutement IDF Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- Patients with metastatic solid tumor

- Age> 18 years

- Signed consent


- Patients with diseases associated with vascular lesions known.

- Patients protected by law, in accordance with Articles L1121-5 to L1121-8 of the
Code of Public Health.

- Mental pathology that can interfere with the proper conduct of the study.

- Refusal of consent.